Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-07-23No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study.Journal of Psychopharmacology · 2026-07-22Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]ClinicalTrials.gov · 2026-07-20Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder.Journal of Psychopharmacology · 2026-07-15Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the BrainClinicalTrials.gov · 2026-07-09Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use DisorderClinicalTrials.gov · 2026-07-08Psilocybin-Assisted Therapy for Prolonged GriefClinicalTrials.gov · 2026-06-22Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-AnalysisPsychiatry International · 2026-06-14Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26Psilocybin-assisted Cognitive Behavioral Therapy for DepressionClinicalTrials.gov · 2026-05-18Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive DisorderClinicalTrials.gov · 2026-05-03Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in ratsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-04-30Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoformsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-04-30Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening StudyRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-04-30Safety Profile of 25 mg Psilocybin in Individuals With Cocaine Use DisorderClinicalTrials.gov · 2026-04-06The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-03-17Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative reviewSchizophrenia Research · 2026-03-12Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse PreventionAddiction Biology · 2026-02-28Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative reviewBMJ Supportive & Palliative Care · 2026-02-17Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb PainClinicalTrials.gov · 2026-01-08The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysisBMC Psychology · 2026-01-01Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal StudiesVCU Scholars Compass (Virginia Commonwealth University) · 2025-12-31Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration modelNeuroscience Applied · 2025-12-31Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled TrialsJournal of Clinical Medicine · 2025-12-28Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online surveyPLOS mental health. · 2025-12-25Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in SwitzerlandmedRxiv · 2025-11-30Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older AdultsClinicalTrials.gov · 2025-10-20An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic TherapyClinicalTrials.gov · 2025-09-25Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley ratsJournal of Psychopharmacology · 2025-09-21Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trialJournal of Psychopharmacology · 2025-08-28Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-CompassionResearch Square · 2025-08-21Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-06-30Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposureFrontiers in Neurology · 2025-06-24Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.Scientific data · 2025-06-17Comparison of the Effects of PEX20 (Oral Psilocin), PEX30 (Sublingual Psilocin), and PEX10 (Oral Psilocybin) in Healthy AdultsClinicalTrials.gov · 2025-06-09Psilocybin’s acute and persistent brain effects: a precision imaging drug trialScientific Data · 2025-06-04Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.Unknown journal · 2025-06-03The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.Psychiatry research · 2025-05-31Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell ModelRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2024-12-31The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implicationsTrends in Anaesthesia and Critical Care · 2024-11-30Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trialsJournal of Psychopharmacology · 2024-10-30An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II DisorderClinicalTrials.gov · 2024-09-24Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depressionNature Mental Health · 2024-08-04Psilocybin desynchronizes the human brainNature · 2024-07-16Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry methodJournal of Chromatography A · 2024-07-03Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility StudyFOCUS The Journal of Lifelong Learning in Psychiatry · 2024-06-30Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trialScientific Reports · 2024-04-16The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.Unknown journal · 2023-12-31[The nursing role in psychedelic-assisted psychotherapy].Revue de l'infirmiere · 2023-12-31Within-subject comparison of near-death and psychedelic experiences: acute and enduring effectsNeuroscience of Consciousness · 2023-12-31Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends AnalysisJMIR Formative Research · 2023-11-27The potential use of psilocybin in psychiatryLithuanian University of Health Sciences · 2023-11-13Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance testPsychopharmacology · 2023-10-18Psilocybin desynchronizes brain networksmedRxiv · 2023-08-23use of psilocybin in the treatment of psychiatric disorders - reviewJournal of Education Health and Sport · 2023-08-14Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptomsJournal of Psychopharmacology · 2023-06-29Psychedelics reopen the social reward learning critical periodNature · 2023-06-13Psilocybin-Based Breakthroughs in Natural MedicineCase Reports and Reviews · 2023-04-29Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trialJournal of Psychopharmacology · 2023-03-19Post-traumatic stress symptoms, post-traumatic stress disorder, and post-traumatic growth among cancer survivors: a systematic scoping review of interventions.Unknown journal · 2023-01-11Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.Frontiers in psychiatry · 2022-12-31Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndromePsychopharmacology · 2022-12-04DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in MetabolitesApplied and Environmental Microbiology · 2022-11-28Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.Unknown journal · 2022-09-11Evaluation of Psilocybin in Anorexia Nervosa: Safety and EfficacyClinicalTrials.gov · 2022-07-24Production and extraction of psilocybin and psilocin from Psilocybe spp. mushroomsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DADRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanismsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05Psilocybe mexicana R. Heim - Mexikanischer KahlkopfZeitschrift für Phytotherapie · 2022-03-31Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.Unknown journal · 2021-11-16Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.Frontiers in Psychiatry · 2021-08-05Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions.Journal of Psychoactive Drugs · 2021-07-15Binding Interactions of Psilocin and Serotonin in the 5-HT2A ReceptorVTechWorks (Virginia Tech) · 2020-05-04Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting AbilitiesVCU Scholars Compass (Virginia Commonwealth University) · 2019-12-31New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological IssuesCurrent Addiction Reports · 2019-04-22Attitudes Toward Medical PsychedelicsDominican Scholar (Dominican University of California) · 2019-04-171.13 Microdosing of Hallucinogens Among College Students: Frequency, Correlates, and ConsequencesJournal of the American Academy of Child & Adolescent Psychiatry · 2018-09-30Biological Effects and Biodistribution of Bufotenine on Mice.Unknown journal · 2018-05-30Unlearning to See: Linking the Perceptual and Clinical Effects of Psychedelic Drugs.eScholarship (California Digital Library) · 2017-12-31If you give a mouse a mushroom: Behavioral effects of hallucinogens in miceeScholarship (California Digital Library) · 2017-12-31DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in "grow-kits" seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocin.Journal of Pharmaceutical and Biomedical Analysis · 2016-03-22Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and PsilocinJournal of Analytical & Bioanalytical Techniques · 2014-12-31Phylogenetic and chemical studies in the potential psychotropic species complex of Psilocybe atrobrunnea with taxonomic and nomenclatural notes.Persoonia - Molecular Phylogeny and Evolution of Fungi · 2014-10-20Psychedelic Research Resurrected: The Contributions of Stanislav GrofCIIS Digital Commons (California Institute of Integral Studies) · 2013-12-31Stanislav Grof's Contributions to FDA Drug Development Research with PsychedelicsCIIS Digital Commons (California Institute of Integral Studies) · 2013-12-31Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Schizophrenia Bulletin · 2012-10-07Other Times I Can Barely See: The Effects of Hallucinogens on Vision and AttentioneScholarship (California Digital Library) · 2009-12-31Hallucinogen persisting perception disorder after psilocybin consumption: a case study.European Psychiatry · 2005-07-31[The morphofunctional changes in the internal organs in the modelling of poisonings by psilocybine-containing mushrooms].Unknown journal · 1999-04-30[The forensic chemical study of psilocybine-containing fungi].Unknown journal · 1998-10-31Analysis of psilocin in Polish hallucinogenic mushroomsActa Poloniae Toxicologica · 1997-12-31Review of Enquiries made to the NPIS Concerning Psilocybe Mushroom Ingestion, 1978-1981Human Toxicology · 1983-03-31Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.Unknown journal · 1980-03-30A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*Schizophrenia Bulletin · 1976-12-31Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.Unknown journal · 1974-12-31